Medication-related osteonecrosis of the jaw: An institution’s experience

References

• Thumbigere-Math V, Michalowicz BS, Hughes PJ, et al. Serum markers of bone turnover and angiogenesis in patients with bisphosphonate-related osteonecrosis of the jaw after discontinuation of long-term intravenous bisphosphonate therapy. J Oral Maxillofac Surg. 2016;74:738–746.
   PubMed Web of Science ®Google Scholar
• Reich W, Bilkenroth U, Schubert J, et al. Surgical treatment of bisphosphonate-associated osteonecrosis: prognostic score and long-term results. J Craniomaxillofac Surg. 2015;43:1809–1822.
   PubMed Web of Science ®Google Scholar
• Fliefel R, Tröltzsch M, Kühnisch J, et al. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. Int J Oral Maxillofac Surg. 2015;44:568–585.
   PubMed Web of Science ®Google Scholar
• Clézardin P. Mechanisms of action of bisphosphonates in oncology: a scientific concept evolving from antiresorptive to anticancer activities. Bonekey Rep. 2013;2:267–273.
   PubMedGoogle Scholar
• Spanou A, Lyritis G, Chronopoulos E, et al. Management of bisphosphonate‐related osteonecrosis of the jaw: a literature review. Oral Dis. 2015;21:927–936.
   PubMed Web of Science ®Google Scholar
• Aghaloo TL, Tetradis S. Osteonecrosis of the jaw in the absence of antiresorptive or antiangiogenic exposure: a series of 6 cases. J Oral Maxillofac Surg. 2017;75:129–142.
   PubMed Web of Science ®Google Scholar
• Cassoni A, Romeo U, Terenzi V, et al. Adalimumab: another medication related to osteonecrosis of the jaws? Case Rep Dent. 2016;2016:1–6.
   Web of Science ®Google Scholar
• Baur DA, Altay MA, Teich S, et al. Osteonecrosis of the jaw in a patient on raloxifene: a case report. Quintessence Int. 2015;46:423–428.
   PubMed Web of Science ®Google Scholar
• Owosho AA, Estilo CL, Huryn JM, et al. Pentoxifylline and tocopherol in the management of cancer patients with medication-related osteonecrosis of the jaw: an observational retrospective study of initial case series. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122:455–459.
   PubMed Web of Science ®Google Scholar
• Ruggiero SL, Dodson TB, Fantasia J, et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg. 2014;72:1938–1956.
   PubMed Web of Science ®Google Scholar
• Lombard T, Neirinckx V, Rogister B. Medication-related osteonecrosis of the jaw: new insights into molecular mechanisms and cellular therapeutic approaches. Stem Cells Int. 2016;2016:1–16.
   Web of Science ®Google Scholar
• Rupel K, Ottaviani G, Gobbo M, et al. A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ). Oral Oncol. 2014;50:1049–1057.
   PubMed Web of Science ®Google Scholar
• Williams WB, O’Ryan F. Management of medication-related osteonecrosis of the jaw. Oral Maxillofac Surg Clin North Am. 2015;27:517–525.
   PubMed Web of Science ®Google Scholar
• Rugani P, Acham S, Kirnbauer B, et al. Stage-related treatment concept of medication-related osteonecrosis of the jaw—a case series. Clin Oral Investig. 2015;19:1329–1338.
   PubMed Web of Science ®Google Scholar
• Minamisako MC, Ribeiro GH. Medication-related osteonecrosis of jaws: a low-level laser therapy and antimicrobial photodynamic therapy case approach. Case Rep Dent. 2016;2016:1–4.
   Web of Science ®Google Scholar
• Montebugnoli L, Felicetti L, Gissi DB, et al. Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:473–477.
   PubMed Web of Science ®Google Scholar
• Scoletta M, Arduino PG, Dalmasso P, et al. Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110:46–53.
   PubMed Web of Science ®Google Scholar
• Vescovi P, Merigo E, Meleti M, et al. Bisphosphonates‐related osteonecrosis of the jaws: a concise review of the literature and a report of a single‐centre experience with 151 patients. J Oral Pathol Med. 2012;41:214–221.
   PubMed Web of Science ®Google Scholar
• Wutzl A, Pohl S, Sulzbacher I, et al. Factors influencing surgical treatment of bisphosphonate-related osteonecrosis of the jaws. Head Neck. 2012;34:194–200.
   PubMed Web of Science ®Google Scholar
• Lopes RN, Rabelo GD, Rocha AC, et al. Surgical therapy for bisphosphonate-related osteonecrosis of the jaw: six-Year Experience of a Single Institution. J Oral Maxillofac Surg. 2015;73:1288–1295.
   PubMed Web of Science ®Google Scholar
• Carlson ER. Management of antiresorptive osteonecrosis of the jaws with primary surgical resection. J Oral Maxillofac Surg. 2014;72:655.
   PubMed Web of Science ®Google Scholar
• Hayden RE, Mullin DP, Patel AK. Reconstruction of the segmental mandibular defect: current state of the art. Curr Opin Otolaryngol Head Neck Surg. 2012;20:231–236.
   PubMed Web of Science ®Google Scholar
• Moura LB, Carvalho PH, Xavier CB, et al. Autogenous non-vascularized bone graft in segmental mandibular reconstruction: a systematic review. Int J Oral Maxillofac Surg. 2016;45:1388–1394.
   PubMed Web of Science ®Google Scholar
• Gadre PK, Ramanojam S, Patankar A, et al. Nonvascularized bone grafting for mandibular reconstruction: myth or reality? J Craniofac Surg. 2011;22:1727–1735.
   PubMed Web of Science ®Google Scholar
• Chiapasco M, Colletti G, Romeo E, et al. Long-term results of mandibular reconstruction with autogenous bone grafts and oral implants after tumor resection. Clin Oral Implants Res. 2008;19:1074–1080.
   PubMed Web of Science ®Google Scholar
• Mooren RE, Merkx MA, Kessler PA, et al. Reconstruction of the mandible using preshaped 2.3-mm titanium plates, autogenous cortical bone plates, particulate cancellous bone, and platelet-rich plasma: a retrospective analysis of 20 patients. J Oral Maxillofac Surg. 2010;68:2459–2467.
   PubMed Web of Science ®Google Scholar